2023
DOI: 10.1016/j.beha.2023.101525
|View full text |Cite
|
Sign up to set email alerts
|

Best practice & research clinical haematology: Screening for breast cancer in hodgkin lymphoma survivors

Stephanie M. Wong
Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
0
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 64 publications
0
0
0
Order By: Relevance
“…Detecting breast cancer early remains essential, as scientific data has indicated that cHL survivors tend to have poorer OS outcomes compared with women diagnosed with de novo breast cancer [34]. A recent review published by Wong [35 ▪▪ ] summarizes practical points and addresses issues regarding effective breast cancer screening. Women with a history of chest radiation for Hodgkin lymphoma are advised to commence screening with bilateral breast MRI at 25 years of age or 8 years after radiation therapy [35 ▪▪ ,36,37].…”
Section: Second Malignancymentioning
confidence: 99%
See 1 more Smart Citation
“…Detecting breast cancer early remains essential, as scientific data has indicated that cHL survivors tend to have poorer OS outcomes compared with women diagnosed with de novo breast cancer [34]. A recent review published by Wong [35 ▪▪ ] summarizes practical points and addresses issues regarding effective breast cancer screening. Women with a history of chest radiation for Hodgkin lymphoma are advised to commence screening with bilateral breast MRI at 25 years of age or 8 years after radiation therapy [35 ▪▪ ,36,37].…”
Section: Second Malignancymentioning
confidence: 99%
“…A recent review published by Wong [35 ▪▪ ] summarizes practical points and addresses issues regarding effective breast cancer screening. Women with a history of chest radiation for Hodgkin lymphoma are advised to commence screening with bilateral breast MRI at 25 years of age or 8 years after radiation therapy [35 ▪▪ ,36,37].…”
Section: Second Malignancymentioning
confidence: 99%